These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 31656149
1. First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis. Acero-Garcés DO, García-Perdomo HA. Curr Pediatr Rev; 2020; 16(1):61-70. PubMed ID: 31656149 [Abstract] [Full Text] [Related]
2. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, Faranoush M, Ehsani MA. Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878 [Abstract] [Full Text] [Related]
3. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T. J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [Abstract] [Full Text] [Related]
7. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ, Acute ITP Study Group. J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411 [Abstract] [Full Text] [Related]
9. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Blackhouse G, Xie F, Levine MA, Campbell K, Assasi N, Gaebel K, O'Reilly D, Tarride J, Goeree R. J Popul Ther Clin Pharmacol; 2012 Apr; 19(2):e166-78. PubMed ID: 22580389 [Abstract] [Full Text] [Related]
10. Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia. Kim CH, Choi YS, Moon JY, Kim DY, Lee SY, Lee HJ, Yun HJ, Kim S, Jo DY, Song IC. Korean J Intern Med; 2019 Mar; 34(2):383-389. PubMed ID: 29172399 [Abstract] [Full Text] [Related]
11. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience. Alioglu B, Ercan S, Tapci AE, Zengin T, Yazarli E, Dallar Y. Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649 [Abstract] [Full Text] [Related]
16. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. Ancona KG, Parker RI, Atlas MP, Prakash D. J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690 [Abstract] [Full Text] [Related]
17. Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis. Ren X, Zhang M, Zhang X, Zhao P, Zhai W. BMC Pediatr; 2024 Mar 21; 24(1):199. PubMed ID: 38515126 [Abstract] [Full Text] [Related]
18. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Gereige RS, Barrios NJ. P R Health Sci J; 2000 Mar 21; 19(1):15-8. PubMed ID: 10761200 [Abstract] [Full Text] [Related]